Molecular Imaging and Radionuclide Therapy (ISSN 2147-1959, 2146-1414) is an open-access journal published by Galenos Publishing House in Turkey. It covers Medicine and Radiology & Nuclear Medicine and Imaging. It is indexed in Scopus, Web of Science, PubMed and HEC. Recorded metrics: impact factor 0.9, Scopus Q3, Web of Science Q4, CiteScore 1.5 and HEC X-Category. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Molecular Imaging and Radionuclide Therapy
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q3 journals · Q4 journals · HEC X category journals · Scopus journals · Web of Science journals · PubMed journals · SCImago journals · ESCI journals · Impact factor journals · Open access journals
Quick answers about Molecular Imaging and Radionuclide Therapy
Is Molecular Imaging and Radionuclide Therapy HEC recognised?
Yes. The catalogue records Molecular Imaging and Radionuclide Therapy in HEC category X of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Molecular Imaging and Radionuclide Therapy indexed in Scopus?
Yes. Molecular Imaging and Radionuclide Therapy is listed as Scopus-indexed, in quartile Q3, with a CiteScore of 1.5. Check its current status on the Scopus Sources page.
Is Molecular Imaging and Radionuclide Therapy in Web of Science?
Yes. Molecular Imaging and Radionuclide Therapy is listed as a Web of Science journal in the Emerging Sources Citation Index (ESCI), with Web of Science quartile Q4. Confirm on Clarivate's Master Journal List.
What is the impact factor of Molecular Imaging and Radionuclide Therapy?
The recorded journal impact factor of Molecular Imaging and Radionuclide Therapy is 0.9. Clarivate updates impact factors every year in Journal Citation Reports.
Is Molecular Imaging and Radionuclide Therapy open access, and what does it charge?
Molecular Imaging and Radionuclide Therapy is an open-access journal. Fees change, so check the journal's website before you submit.
Who publishes Molecular Imaging and Radionuclide Therapy?
Molecular Imaging and Radionuclide Therapy is published by Galenos Publishing House in Turkey, under ISSN 2147-1959 and 2146-1414.
Research profile
- 577articles indexed
- 3,811citations
- 28h-index
- 0.922-year mean citedness
- 1989first year indexed
Main research topics: Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications, Thyroid Cancer Diagnosis and Treatment, Thyroid and Parathyroid Surgery, Lung Cancer Diagnosis and Treatment, Neuroendocrine Tumor Research Advances.
Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.
Browse similar journals
- Medicine journals (8,023)
- Radiology & Nuclear Medicine and Imaging journals (370)
- Journals indexed in Scopus (31,185)
- Journals indexed in Web of Science (22,643)
- Journals indexed in PubMed (16,086)
- Journals indexed in HEC (34,823)
- Scopus Q3 journals (7,077)
- Web of Science Q4 journals (5,444)
- HEC X-Category journals (9,306)
- Journals published in Turkey (457)
- Galenos Publishing House journals (38)